Sphingosine-1-Phosphate Receptor 3 Promotes Recruitment of Monocyte/Macrophages in Inflammation and Atherosclerosis
- 4 February 2011
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation Research
- Vol. 108 (3), 314-323
- https://doi.org/10.1161/circresaha.110.235028
Abstract
Rationale: The role of sphingosine-1-phosphate (S1P) and its receptors in the pathogenesis of atherosclerosis has not been investigated. Objective: We hypothesized that the S1P receptor 3 (S1P3) plays a causal role in the pathogenesis of atherosclerosis. Methods and Results: We examined atherosclerotic lesion development in mice deficient for S1P3 and apolipoprotein (Apo)E. Although S1P3 deficiency did not affect lesion size after 25 or 45 weeks of normal chow diet, it resulted in a dramatic reduction of the monocyte/macrophage content in lesions of S1P3−/−/ApoE−/− double knockout mice. To search for putative defects in monocyte/macrophage recruitment, we examined macrophage-driven inflammation during thioglycollate-induced peritonitis. Elicited peritoneal macrophages were reduced in S1P3-deficient mice and expressed lower levels of tumor necrosis factor-α and monocyte chemoattractant protein-1. Bone marrow–derived S1P3-deficient macrophages produced less MCP-1 in response to lipopolysaccharide stimulation. In vitro, S1P was chemotactic for wild-type but not S1P3-deficient peritoneal macrophages. In vivo, S1P concentration increased rapidly in the peritoneal cavity after initiation of peritonitis. Treatment with the S1P analog FTY720 attenuated macrophage recruitment to the peritoneum. Studies in bone marrow chimeras showed that S1P3 in both hematopoietic and nonhematopoietic cells contributed to monocyte/macrophage accumulation in atherosclerotic lesions. Finally, S1P3 deficiency increased the smooth muscle cell content of atherosclerotic lesions and enhanced neointima formation after carotid ligation arguing for an antiproliferative/antimigratory role of S1P3 in the arterial injury response. Conclusions: Our data suggest that S1P3 mediates the chemotactic effect of S1P in macrophages in vitro and in vivo and plays a causal role in atherosclerosis by promoting inflammatory monocyte/macrophage recruitment and altering smooth muscle cell behavior.Keywords
This publication has 32 references indexed in Scilit:
- Inhibitory Role of Sphingosine 1-Phosphate Receptor 2 in Macrophage Recruitment during InflammationThe Journal of Immunology, 2009
- Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasisNature, 2009
- Activation of Sphingosine Kinase-1 Reverses the Increase in Lung Vascular Permeability Through Sphingosine-1-Phosphate Receptor Signaling in Endothelial CellsCirculation Research, 2008
- HDL-Associated Lysosphingolipids Inhibit NAD(P)H Oxidase-Dependent Monocyte Chemoattractant Protein-1 ProductionArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Sphingosine-1-Phosphate Receptor Subtypes Differentially Regulate Smooth Muscle Cell PhenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Sphingosine-1-Phosphate Induces an Antiinflammatory Phenotype in MacrophagesCirculation Research, 2008
- Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromataJCI Insight, 2007
- Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaquesJCI Insight, 2007
- Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependentThe Journal of Experimental Medicine, 2006
- Predicting obstructive coronary artery disease with serum sphingosine-1-phosphateAmerican Heart Journal, 2003